Martijn J. ter Borg

Early on‐treatment prediction of response to peginterferon alfa‐2a for HBeAg‐negative chronic hepatitis B using HBsAg and HBV DNA levels†

Vincent Rijckborst, Bettina E. Hansen, Yılmaz Çakaloğlu et al. · Hepatology · 2010 · 237 citations · Full text

Exacerbation of chronic hepatitis B infection after delivery

Martijn J. ter Borg, W. F. Leemans, Robert A. de Man et al. · Journal of Viral Hepatitis · 2007 · 195 citations

A Randomized Trial of Peginterferon α-2a With or Without Ribavirin for HBeAg-Negative Chronic Hepatitis B

Vincent Rijckborst, Martijn J. ter Borg, Yılmaz Çakaloğlu et al. · The American Journal of Gastroenterology · 2010 · 93 citations

α-Galactosylceramide in Chronic Hepatitis B Infection: Results from a Randomized Placebo-Controlled Phase I/ II Trial

Andrea M. Woltman, Martijn J. ter Borg, Rekha S. Binda et al. · Antiviral Therapy · 2008 · 87 citations

Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: Relation to treatment response

Martijn J. ter Borg, Monika van Zonneveld, Stefan Zeuzem et al. · Hepatology · 2006 · 70 citations